Treatment of superficial thrombophlebitis;Behandlung der oberflächlichen thrombophlebitis

Hamostaseologie

Volumn 22, Issue 4, 2002, Pages 149-153

  Raake, W ^a   Binder, M ^a  

^a Daiichi Sankyo Europe GmbH   (Germany)

Author keywords

Heparin; Mucopolysaccharide polysulfate; Thrombophlebitis; Topical treatment

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; FLAVANOID; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

CHEMICAL STRUCTURE; CHRONIC VEIN INSUFFICIENCY; COMPRESSION THERAPY; CREAM; DIAGNOSTIC IMAGING; DRUG EFFICACY; EDEMA; FIBRINOLYTIC THERAPY; GEL; HUMAN; INFLAMMATION; PAIN; REVIEW; RISK FACTOR; THROMBOPHLEBITIS; TREATMENT INDICATION;

EID: 0036922239     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619557     Document Type: Review

References (29)

1. Beatty J, Fitridge R, Benveniste G et al. Acute superficial venous thrombophlebitis: Does emergency surgery have a role? Int Angiol 2002;21:93-5.
2. Belcaro G, Nicolaides AN, Errichi BM et al. Superficial thrombophlebitis of the legs: A randomized, controlled, follow-up study. Angiology 1999;50:523-9.
3. Blumenberg RM, Barton E, Gelfand ML et al. Occult deep venous thrombosis complicating superficial thrombophlebitis. J Vasc Surg 1998; 27:338-43.
4. Bounameaux H, Reber-Wasem MA. Superficial thrombophlebitis and deep vein thrombosis. A controversial association. Arch Intern Med 1997;157:1822-4.
5. Denzel C, Lang W. Die Diagnostik und Therapie der progressiven Thrombophlebitis epifaszialer Beinvenen. Zentralbl Chir 2001; 126: 374-8.
6. Diehm C, Trampisch HJ, Lange S et al. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 1996; 347:292-4.
7. Downing LJ, Strieter RM, Kadell AM et al. Low-dose-low-molecular-weight heparin is antiinflammatory during venous thrombosis. J Vasc Surg 1998;28:848-54.
8. Egg, D. Effects of glycosamino-glycan-polysulfate and two non-steroidal anti-inflammatory drugs on prostaglandin E2 synthesis in Chinese hamster ovary cell cultures. Pharmacol Res Commun 1983;15:709-17.
9. th ed). Mosby-Year Book 1998.
10. th ed). Mosby-Year Book; 1998.
11. Fenton JW, Ofosu FA, Brezniak DV et al. Thrombin and antithrombotics. Semin Thromb Hemost 1998; 24: 87-91.
12. Görög P, Raake W. Antithrombotic effect of a mucopolysaccharide polysulfate after systemic, topical and percutaneous application. Arzneim Forsch (Drug Res) 1987; 37: 342-5.
13. Hästbacka J, Tammisto T. Hirudoid® ointment in the prevention of infusion thrombophlebitis. Nord Med 1967;14:444-5.
14. Hoppensteadt DA, Fareed J, Raake P et al. Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates. Thromb Res 2001;103: 157-63.
15. Klöcking HP, Raake W. Enhancement of t-PA relase by mucopolysaccharide polysulfate. Thromb Res 1992;66:89-92.
16. Kowalsky BL, Budde R. Perkutane Heparinoidtherapie bei postoperativen Infusionsthrombophlebitiden (Klinischer Doppel-blindversuch). Therapiewoche 1978;28:7260-3.
17. Kurz X, Kahn SR, Abenhaim L et al. Chronic venous disorders of the leg: Epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the veines task force. Int Angiol 1999;18:83-102.
18. Lane DA, Michalski R, van Ross ME et al. Comparison of heparin and a semi-synthetic heparin analogue. Br J Haematol 1977;37: 239-45.
19. Lipecz J, Bihler K. Prevention and treatment of infusion thrombophlebitis with an organoheparinoid ointment. Med Welt 1969;20: 1662-5.
20. MacGregor IR. Stimulation of urokinase activity by the polysulphated glycosaminoglycan present in Hirudoid®. IRCS Med Sci 1986;14: 687-8.
21. Mehta PP, Sagar S, Kakkar VV. Treatment of superficial thrombophlebitis: A randomized, double-blind trial of heparinoid cream. Brit Med J 1975;3:614-6.
22. NN. Leitlinien Phlebologie. Diagnostik und Therapie der Thrombophlebitis superficialis. Hautarzt 1998;10:585-6.
23. Petruzellis V, Troccoli T, Candiani C et al. Oxerutins (Venoruton): Efficacy in chronic venous insufficiency - A double-blind randomized, controlled study. Angiology 2002;53: 257-63.
24. Schedel F, Hennemann B, Reindl P. Kontrollierte Studie zur Wirksamkeit einer externen Therapie bei oberflächennaher Thrombophlebitis. Fortschr Med 1977;95:1557-60.
25. Scurr JH, Machin SJ, Baily-King S et al. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: A randomised trial. Lancet 2001;357:1485-9.
26. Stüttgen G, Panse P, Bauer E. Permeation of the human skin by heparin and mucopolysaccharide polysulfuric acid ester. Arzneim Forsch (Drug Res) 1990;40:484-9.
27. Thomas DP, Lane DA, Michalski R et al. A heparin analogue with specific action on antithrombin III. Lancet 1977;1:120-2.
28. Unno N, Mitsuoka H, Uchiyama T et al. Superficial thrombophlebitis of the lower limbs in patients with varicose veins. Surg Today 2002; 32:397-401.
29. Mukopolysaccharidpolyschwefelsäureester (MPSSE) zur Topischen Anwendung. Bundesanzeiger 22.04.1992.